Clinical Trial Update: Clinical Study of Induction Therapy Options Based on Molecular Subtyping and MRD in Children and Adolescents With AML [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial in children and adolescents with acute myeloid leukemia evaluating induction therapy options based on molecular subtyping and measurabl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: Children's Hospital of Soochow University | Conditions: AML, Childhood, Acute Myeloid Leukemia | Phase 2 | Status: RECRUITING